Friday, 2 November 2018

U.S. FDA approves AcelRx Pharma's opioid pain drug

The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based fast-acting treatment for pain to be used under medical supervision.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)